Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01505257 · ClinicalTrials.gov registry record · NA
Early Nurse Detection and Management of Delirium
A NA study, sponsored by Penn State University.
- Completed
- Registry status
- NA
- Development phase
- 391
- Enrollment target
NCT01505257: Completed NA study, sponsored by Penn State University.
NCT01505257 is a NA study that has completed, run by Penn State University. The registered enrollment target is 391 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01505257, a NA study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 391 participants
- Enrollment target
Study Summary
Delirium (acute confusion) is common and costly in persons with dementia, resulting in longer hospital stays, more complications, and greater functional decline. This research tests the use of the electronic health record, education, and regular feedback to nurses to improve detection and management of delirium. Ultimately, findings will direct ways to improve acute care of this vulnerable population.
Primary Outcome
Measured using the Delirium Rating Scale R-98.
Interventions
- BEHAVIORAL END-DSD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 391 participants |
| Start Date | 2010-04 |
| Est. Completion | 2015-02 |
| Phase | NA |
What the finished NCT01505257 record still lists
NCT01505257 is an interventional study that assigns participants to a tested intervention. The registered 391 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 1 intervention - of which END-DSD is the first listed.
NCT01505257 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01505257 about?
NCT01505257 is a clinical study titled "Early Nurse Detection and Management of Delirium". Delirium (acute confusion) is common and costly in persons with dementia, resulting in longer hospital stays, more complications, and greater functional decline. This research tests the use of the electronic health record, education, and regular feedback to nurses to improve detection and management...
What is the current status of trial NCT01505257?
This trial is currently completed. It is a NA study. The enrollment target is 391 participants. The study started on 2010-04. Estimated completion is 2015-02.
What interventions are being tested in trial NCT01505257?
The interventions under investigation include: END-DSD (BEHAVIORAL).
Who is sponsoring clinical trial NCT01505257?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01505257's enrollment target sits among peer trials
391 269th of 2000 higher than 1,732 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06397703 · 392 participants · Phase 2
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
- NCT06625775 · 392 participants · Phase 1
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- NCT07220967 · 392 participants · Phase 4
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
- NCT07290036 · 392 participants · Phase 1
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia